Anti-retroviral treatment to HIV positive South Africans will be dramatically advanced after government concluded a R24 billion deal with Aspen Pharmacare to intensify manufacturing of antiretroviral drugs (ARVs).
Trade and Industry Minister, Rob Davies, says the agreement will help stimulate local manufacturing, adding that,” That ARV tender has fought a lot of mays and ifs and buts about it, but an indicative target of 70 percent local procurement…”
The massive tender aims to improve ARV supplies to patients and will also be a massive cash injection for local producers. Foreign manufacturers will also have to invest and produce in South Africa to take advantage of the local procurement clause.”
To read the article titled, “ARV's provision to HIV positive persons to advance next year,” click here.